Public Profile

Alfasigma USA Inc.

Alfasigma USA Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States and operates extensively across North America. Founded in 2015, the company has quickly established itself as a leader in the development and distribution of innovative healthcare solutions. Specialising in prescription pharmaceuticals, Alfasigma focuses on therapeutic areas such as gastroenterology, central nervous system disorders, and women's health. Their core products are distinguished by their commitment to quality and efficacy, addressing unmet medical needs with a patient-centric approach. With a strong market position, Alfasigma USA Inc. has achieved notable milestones, including strategic partnerships and a growing portfolio of proprietary medications. The company continues to enhance its reputation as a trusted provider of advanced therapeutic options in the competitive pharmaceutical landscape.

DitchCarbon Score

How does Alfasigma USA Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

18

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

19

Industry Benchmark

Alfasigma USA Inc.'s score of 18 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.

23%

Let us know if this data was useful to you

Alfasigma USA Inc.'s reported carbon emissions

Alfasigma USA Inc. currently does not provide specific carbon emissions data, as there are no available figures for their emissions in kg CO2e. Consequently, details regarding their Scope 1, 2, or 3 emissions are also absent. In the absence of concrete emissions data, it is important to note that Alfasigma USA Inc. has not outlined any formal reduction targets or commitments to climate initiatives. This lack of publicly available information suggests that the company may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the industry increasingly prioritises sustainability and carbon reduction, Alfasigma USA Inc. may need to establish clear climate commitments and measurable targets to align with global efforts in combating climate change.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Alfasigma USA Inc.'s primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Alfasigma USA Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Alfasigma USA Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers